Gabapentin (Neurontin® (Registered Trademark))

DRUG3 trials

Sponsors

National Institute of Mental Health (NIMH), Haroon Muhammad Khalil, Viatris Inc.

Conditions

Analgesia, PostoperativeAnxiety DisorderHealthy Non-dependent, Recreational Sedative UsersMood DisorderPain ManagementPsychotic Disorder

Phase 2

New Drugs in the Treatment of Mood Disorders

CompletedNCT00001482

National Institute of Mental Health (NIMH)Anxiety Disorder, Mood Disorder, Psychotic Disorder

Start: 1995-05-31End: 2001-05-31Target: 60Updated: 2008-03-04

Phase 4

Abuse Potential of Oral Gabapentin in Healthy, Non-Drug-Dependent Individuals With Recreational Sedative Drug Use Experience

CompletedNCT07777965

Viatris Inc.Healthy Non-dependent, Recreational Sedative Users

Start: 2026-06-18End: 2026-08-31Updated: 2026-09-08

Unknown Phase

Pain Management Protocol in Abdominal Surgeries in City of Erbil

Active, not recruitingNCT07019103

Haroon Muhammad KhalilAnalgesia, Postoperative, Pain Management

Start: 2025-03-02End: 2026-11-15Target: 136Updated: 2025-06-13